PRE-MARKET CHINESE AND HONG KONG STOCK NEWS: Anta and FILA Q3 retail sales decline; Sands China Q3 net income falls c. 30%; China Life to sell Pension Company stake to parent; Frontage halted pending takeovers announcement

Anta Sports (2020 HK) - Q3 2026 retail sales: ANTA brand mid-single-digit decline Y/Y, FILA low-single-digit decline Y/Y, all other brands +25-30% Y/Y. (HKEX filing)

BAIC Motor (1958 HK) - BAIC Investment to exit its entire 33% stake in Beijing Hyundai Auto Finance via a capital reduction for CNY 2.21bln, while Beijing Hyundai will exit its 14% stake for CNY 936.6mln; subject to shareholder approval. (HKEX filing)

Cathay Pacific (293 HK) - September passengers carried by Cathay Pacific and HK Express c. 3mln (+9% Y/Y); cargo carried over 150k tonnes (+14% Y/Y). (HKEX filing)

China Life Insurance (2628 HK) - To sell a 33.73% stake in China Life Pension Company to parent CLIC for CNY 4.15bln, with subsidiary AMC selling its 3.53% stake for CNY 433.9mln; Pension Company will cease to be a subsidiary, with China Life's holding reduced to 37.01% from 70.74%. (HKEX filing)

China State Construction International (3311 HK) - 9M 2026 (CNY): Revenue 59.11bln (prev. 77.70bln Y/Y), Operating Profit and Share of JV Profits 9.86bln (prev. 11.92bln Y/Y). (HKEX filing)

Hangzhou Tigermed (3347 HK) / Frontage Holdings (1521 HK) - Frontage shares halted from 09:00 HKT today pending an announcement under the Takeovers Code containing inside information. (HKEX filing)

Sands China (1928 HK) - Q3 2026 (USD): Net Income 191mln (prev. 272mln Y/Y), Net Revenue 1.93bln (+1.4% Y/Y). (LVS earnings release/HKEX filing)

Shimao Group (813 HK) - Receivers agreed to sell the Group's hotels and hotel business to Oceanfront Hong Kong for HKD 2.7bln (subject to adjustment). (HKEX filing)

Sinopec Engineering (2386 HK) - 9M 2026 new contract value CNY 61.35bln, of which Q3 CNY 9.44bln. (HKEX filing)

Sun Hung Kai Properties (16 HK) - Sold all 128 flats offered at listed prices in the latest batch of its Sierra Sea project on Wednesday. (SCMP)

Tencent (700 HK) - Completed the issue of USD 1.8bln and CNY 26bln of notes under its GMTN programme. (HKEX filing)

• Beijing Energy International (686 HK) - Q3 2026 electricity generation c. 7.99mln MWh; 9M c. 20.72mln MWh. (HKEX filing)
• Hong Kong IPOs - At least three companies have shelved Hong Kong listings after launching share sales since July amid tougher oversight and weak demand, with Jiangsu Slender West Lake Culture and Tourism postponing a HKD 227mln listing on Tuesday. (SCMP)
• Voyah Automotive (7489 HK) - Received listing approval from HKEX for the H Share Full Circulation of certain domestic shares. (HKEX filing)
• Weichai Power (2338 HK) - Parent Weichai Holdings has bought 7.923mln A shares (c. 0.09%) under its shareholding increase plan as of 21st October. (HKEX filing)
• Xuanzhu Biopharmaceutical (2575 HK) / Sihuan Pharmaceutical (460 HK) - Presented Phase III data for Anaprazole Sodium in reflux esophagitis as a late-breaking abstract at UEG Week 2026. (HKEX filing)

This reads as a Hong Kong pre-market corporate tape rather than a single market-moving print, and the useful precedent is that mixed filing roundups usually separate into quality of demand, balance-sheet action, and event risk rather than moving the index as one block. Anta is the clear internal split: the headline shows ANTA and FILA declining while the other brands grow strongly, a pattern in sportswear downturns where legacy franchise inventory and channel clearing lag faster-growing outdoor or niche lines; the tell is whether discounting is confined to FILA/ANTA or starts to follow the smaller brands. Sands China fits the Macau sequence of stable top line with softer net income, where the transmission is less mass-market traffic than hold, premium play, and cost absorption, so margin compression matters more than the revenue tick. China Life and BAIC are related-party or sponsor-adjacent transfers rather than arm's-length exits; those tend to be read through capital recycling and group simplification, with the balance-sheet effect clearer than any valuation signal. Frontage's halt under the Takeovers Code is the discrete event risk: pending takeover announcements in listed CRO or biotech-adjacent names have historically repriced the target first and then pulled peers through read-across, while unrelated IPO shelving in the same tape points to primary-market demand staying selective even where secondary property, as with the Sierra Sea batch, still clears at listed prices. The follow-ons are Anta/FILA channel commentary, Sands hold and premium-mass detail, terms and buyer identity if Frontage resumes, and whether more H-share issuance follows Tencent's note issue while the IPO queue remains fragile.